Fumihiko Kanai
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Six key elements for effective coordination in home-based care for older adults with cancer in Japan: A qualitative interview study.
Journal: Journal of geriatric oncology
Published: December 29, 2025
Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial.
Journal: Liver cancer
Published: August 09, 2019
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 02, 2018
Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-α combination therapy for hepatocellular carcinoma with extrahepatic metastases.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 07, 2017
A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization.
Journal: Hepatology (Baltimore, Md.)
Published: November 24, 2016
Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib.
Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib.
Journal: Investigational new drugs
Published: December 03, 2015
Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
Journal: Investigational new drugs
Published: August 15, 2015
Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
Journal: Ultrasound in medicine & biology
Published: April 18, 2015
Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors.
Journal: Investigational new drugs
Published: February 22, 2015
Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma.
Journal: Anticancer research
Published: January 01, 2015
Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study.
Journal: Hepatology international
Published: October 18, 2014
Last Updated: 09/26/2026